Falcon Point Capital’s Clearside Biomedical CLSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-31,208
Closed -$192K 104
2018
Q3
$192K Buy
31,208
+16,521
+112% +$102K 0.04% 104
2018
Q2
$157K Sell
14,687
-10,027
-41% -$107K 0.03% 116
2018
Q1
$265K Buy
24,714
+89
+0.4% +$954 0.05% 104
2017
Q4
$172K Sell
24,625
-19,594
-44% -$137K 0.03% 115
2017
Q3
$315K Buy
+44,219
New +$315K 0.05% 102